CD44 and neoplasm: Through the esterification of alpha-tocopherol succinate with hyaluronic acid, a novel amphiphilic compound was created for the tumour-targeted delivery system, exploiting the ability of hyaluronic acid to bind to the membrane receptor CD44, a protein overexpressed by tumour cells.